Loading...
Cabot Corporation
CBT•NYSE
Basic Materials
Chemicals - Specialty
$76.13
$0.66(0.87%)
Cabot Corporation (CBT) Financial Performance & Income Statement Overview
Review Cabot Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1.60%
↑ 1.60%
Operating Income Growth
16.73%
↑ 16.73%
Net Income Growth
-14.61%
↓ 14.61%
Operating Cash Flow Growth
16.30%
↑ 16.30%
Operating Margin
16.38%
↑ 16.38%
Gross Margin
24.90%
↑ 24.90%
Net Profit Margin
11.08%
↑ 11.08%
ROE
31.13%
↑ 31.13%
ROIC
21.58%
↑ 21.58%
Cabot Corporation (CBT) Income Statement & Financial Overview
Review Cabot Corporation's (CBT) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $955.00M | $1.001B | $1.02B | $1.02B |
| Cost of Revenue | $720.00M | $761.00M | $759.00M | $773.00M |
| Gross Profit | $235.00M | $240.00M | $257.00M | $246.00M |
| Gross Profit Ratio | $0.25 | $0.24 | $0.25 | $0.24 |
| R&D Expenses | $14.00M | $17.00M | $16.00M | $15.00M |
| SG&A Expenses | $66.00M | $73.00M | $68.00M | $75.00M |
| Operating Expenses | $80.00M | $90.00M | $84.00M | $90.00M |
| Total Costs & Expenses | $800.00M | $851.00M | $843.00M | $863.00M |
| Interest Income | $6.00M | $7.00M | $8.00M | $8.00M |
| Interest Expense | $18.00M | $19.00M | $19.00M | $21.00M |
| Depreciation & Amortization | $37.00M | $37.00M | $36.00M | $37.00M |
| EBITDA | $200.00M | $191.00M | $209.00M | $201.00M |
| EBITDA Ratio | $0.21 | $0.19 | $0.21 | $0.20 |
| Operating Income | $155.00M | $150.00M | $173.00M | $156.00M |
| Operating Income Ratio | $0.16 | $0.15 | $0.17 | $0.15 |
| Other Income/Expenses (Net) | -$11.00M | -$15.00M | -$14.00M | -$14.00M |
| Income Before Tax | $144.00M | $135.00M | $158.00M | $142.00M |
| Income Before Tax Ratio | $0.15 | $0.13 | $0.16 | $0.14 |
| Income Tax Expense | $41.00M | -$10.00M | $40.00M | $47.00M |
| Net Income | $93.00M | $137.00M | $109.00M | $84.00M |
| Net Income Ratio | $0.10 | $0.14 | $0.11 | $0.08 |
| EPS | $1.69 | $2.43 | $1.96 | $1.52 |
| Diluted EPS | $1.67 | $2.48 | $1.94 | $1.51 |
| Weighted Avg Shares Outstanding | $54.30M | $56.38M | $55.10M | $55.40M |
| Weighted Avg Shares Outstanding (Diluted) | $55.00M | $55.20M | $55.70M | $55.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan